Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment Options

Global dissemination of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB) such as carbapenemase-producing Enterobacterales has resulted in reviving colistin as a final therapeutic alternative. Colistin resistance foretold a catastrophe. We aimed to detect th...

Full description

Bibliographic Details
Main Authors: Amal F. Makled, Sahar A.M. Ali, Ahmed B. Mahmoud, Marwa E. Eltoukhy, Reem M. Elkholy, Athar F. Lasheen, Asmaa Mohammed Elbrolosy
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2023-12-01
Series:Journal of Pure and Applied Microbiology
Subjects:
Online Access:https://microbiologyjournal.org/colistin-resistance-among-enterobacterales-isolates-underlying-mechanisms-and-alternative-treatment-options/
_version_ 1797389171406405632
author Amal F. Makled
Sahar A.M. Ali
Ahmed B. Mahmoud
Marwa E. Eltoukhy
Reem M. Elkholy
Athar F. Lasheen
Asmaa Mohammed Elbrolosy
author_facet Amal F. Makled
Sahar A.M. Ali
Ahmed B. Mahmoud
Marwa E. Eltoukhy
Reem M. Elkholy
Athar F. Lasheen
Asmaa Mohammed Elbrolosy
author_sort Amal F. Makled
collection DOAJ
description Global dissemination of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB) such as carbapenemase-producing Enterobacterales has resulted in reviving colistin as a final therapeutic alternative. Colistin resistance foretold a catastrophe. We aimed to detect the rates of carbapenems and colistin resistance among hospital-acquired Enterobacterales species, verify the underlying mechanisms and provide antibiogram for colistin-resistant isolates. The collected Enterobacterales isolates were tested for their antimicrobial susceptibility by the disk diffusion method and agar dilution was utilized for both imipenem and colistin. The production of ESβLs and carbapenemases was phenotypically assessed by the combined disk (CDT) and modified carbapenem inactivation (mCIM) tests, respectively. Possible attributes for colistin resistance were explored by detection of both plasmid- and efflux pump-mediated mechanisms. By multiplex PCR assay, carbapenem resistance (blaNDM-1 & blaOXA-48) and mobilized colistin-resistant-1 (mcr-1) genes were identified. A total of 160 Enterobacterales isolates were obtained of which 68.8% were MDR, 25% were XDR and 6.3% were pandrug-resistant (PDR) isolates with no statistically significant difference among Enterobacterales species (P> 0.05). Carbapenems resistance was detected in 41.3% (66/160) while colistin resistance was detected in 22% (36/160) of isolates. Proteus mirabilis expressed the highest rate of colistin resistance (100%; 16/16), followed by Enterobacter aerogenes (23.1%; 6/26), E. coli (13%; 6/46) and K.pneumoniae (11.1%; 8/72). One hundred percent (36/36) of colistin-resistant isolates proved efflux pump activity for colistin. However; only 2% (2/100) of tested Enterobacterales carried mcr-1 gene through molecular analysis. Colistin-resistant isolates exhibited variable susceptibility to the tested antimicrobial agents of which fosfomycin was the highest (94.1%). Efflux pump activity played a major role for colistin resistance among Enterobacterales species and fosfomycin could be a promising therapeutic option.
first_indexed 2024-03-08T22:51:58Z
format Article
id doaj.art-da6facfad0f64458ab3ebcd09fca4a9a
institution Directory Open Access Journal
issn 0973-7510
2581-690X
language English
last_indexed 2024-03-08T22:51:58Z
publishDate 2023-12-01
publisher Journal of Pure and Applied Microbiology
record_format Article
series Journal of Pure and Applied Microbiology
spelling doaj.art-da6facfad0f64458ab3ebcd09fca4a9a2023-12-16T11:17:43ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2023-12-0117422632280https://doi.org/10.22207/JPAM.17.4.24Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment OptionsAmal F. Makledhttps://orcid.org/0000-0002-2046-537XSahar A.M. Alihttps://orcid.org/0000-0003-3885-0388Ahmed B. Mahmoudhttps://orcid.org/0000-0002-3305-0624Marwa E. Eltoukhyhttps://orcid.org/0000-0002-1122-681XReem M. Elkholyhttps://orcid.org/0000-0002-8062-7086Athar F. Lasheenhttps://orcid.org/0009-0006-2533-3970Asmaa Mohammed Elbrolosyhttps://orcid.org/0000-0001-8196-4511Global dissemination of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB) such as carbapenemase-producing Enterobacterales has resulted in reviving colistin as a final therapeutic alternative. Colistin resistance foretold a catastrophe. We aimed to detect the rates of carbapenems and colistin resistance among hospital-acquired Enterobacterales species, verify the underlying mechanisms and provide antibiogram for colistin-resistant isolates. The collected Enterobacterales isolates were tested for their antimicrobial susceptibility by the disk diffusion method and agar dilution was utilized for both imipenem and colistin. The production of ESβLs and carbapenemases was phenotypically assessed by the combined disk (CDT) and modified carbapenem inactivation (mCIM) tests, respectively. Possible attributes for colistin resistance were explored by detection of both plasmid- and efflux pump-mediated mechanisms. By multiplex PCR assay, carbapenem resistance (blaNDM-1 & blaOXA-48) and mobilized colistin-resistant-1 (mcr-1) genes were identified. A total of 160 Enterobacterales isolates were obtained of which 68.8% were MDR, 25% were XDR and 6.3% were pandrug-resistant (PDR) isolates with no statistically significant difference among Enterobacterales species (P> 0.05). Carbapenems resistance was detected in 41.3% (66/160) while colistin resistance was detected in 22% (36/160) of isolates. Proteus mirabilis expressed the highest rate of colistin resistance (100%; 16/16), followed by Enterobacter aerogenes (23.1%; 6/26), E. coli (13%; 6/46) and K.pneumoniae (11.1%; 8/72). One hundred percent (36/36) of colistin-resistant isolates proved efflux pump activity for colistin. However; only 2% (2/100) of tested Enterobacterales carried mcr-1 gene through molecular analysis. Colistin-resistant isolates exhibited variable susceptibility to the tested antimicrobial agents of which fosfomycin was the highest (94.1%). Efflux pump activity played a major role for colistin resistance among Enterobacterales species and fosfomycin could be a promising therapeutic option.https://microbiologyjournal.org/colistin-resistance-among-enterobacterales-isolates-underlying-mechanisms-and-alternative-treatment-options/enterobacteralescarbapenemscolistinefflux pump & mcr-1 gene
spellingShingle Amal F. Makled
Sahar A.M. Ali
Ahmed B. Mahmoud
Marwa E. Eltoukhy
Reem M. Elkholy
Athar F. Lasheen
Asmaa Mohammed Elbrolosy
Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment Options
Journal of Pure and Applied Microbiology
enterobacterales
carbapenems
colistin
efflux pump & mcr-1 gene
title Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment Options
title_full Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment Options
title_fullStr Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment Options
title_full_unstemmed Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment Options
title_short Colistin Resistance among Enterobacterales Isolates: Underlying Mechanisms and Alternative Treatment Options
title_sort colistin resistance among enterobacterales isolates underlying mechanisms and alternative treatment options
topic enterobacterales
carbapenems
colistin
efflux pump & mcr-1 gene
url https://microbiologyjournal.org/colistin-resistance-among-enterobacterales-isolates-underlying-mechanisms-and-alternative-treatment-options/
work_keys_str_mv AT amalfmakled colistinresistanceamongenterobacteralesisolatesunderlyingmechanismsandalternativetreatmentoptions
AT saharamali colistinresistanceamongenterobacteralesisolatesunderlyingmechanismsandalternativetreatmentoptions
AT ahmedbmahmoud colistinresistanceamongenterobacteralesisolatesunderlyingmechanismsandalternativetreatmentoptions
AT marwaeeltoukhy colistinresistanceamongenterobacteralesisolatesunderlyingmechanismsandalternativetreatmentoptions
AT reemmelkholy colistinresistanceamongenterobacteralesisolatesunderlyingmechanismsandalternativetreatmentoptions
AT atharflasheen colistinresistanceamongenterobacteralesisolatesunderlyingmechanismsandalternativetreatmentoptions
AT asmaamohammedelbrolosy colistinresistanceamongenterobacteralesisolatesunderlyingmechanismsandalternativetreatmentoptions